Limbs & Things Limited

and Subsidiary

Undertakings

 

Registered number: 02532281

 

Directors' report and financial statements

 

For the year ended 31 December 2025

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

COMPANY INFORMATION

 

Directors

C M Cooper

 

R Braso

 

A Allin

 

N Hull

 

T Cooper

 

 

Registered number

02532281

 

 

Registered office

Sussex Street

 

St Philips

 

Bristol

 

BS2 0RA

 

 

Trading Address

Sussex Street

 

St Philips

 

Bristol

 

BS2 0RA

 

 

Independent auditor

Forvis Mazars LLP

 

Chartered Accountants & Statutory Auditor

 

8th Floor, Assembly Building C

 

Cheese Lane

 

Bristol

 

BS2 0JJ

 

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

CONTENTS

 

 

Page

 

 

Group Strategic Report

1-3

 

 

Directors’ Report

4-6

 

 

Independent Auditor’s Report

7-10

 

 

Consolidated Statement of Comprehensive Income

11

 

 

Consolidated Balance Sheet

12

 

 

Company Balance Sheet

13

 

 

Consolidated Statement of Changes in Equity

14-15

 

 

Company Statement of Changes in Equity

16-17

 

 

Consolidated Statement of Cash Flows

18-19

 

 

Consolidated Analysis of Net Debt

20

 

 

Notes to the Financial Statements

21-42

 

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

GROUP STRATEGIC REPORT

FOR THE YEAR ENDED 31 DECEMBER 2025

 

Introduction

 

The directors present their strategic report for the year ended 31 December 2025.

 

Business review

 

The Group's principal activity during the year continued to be the design, manufacture and marketing of medical training products to customers worldwide.

 

The establishment of medical simulation as an industry sector continues and so too does the competition. Limbs & Things Limited continued in its strategy of investing in its people, research and development into new products and into modernising its production methods. The Business continued to work hard to expand its sales network in a competitive sector and has seen a recovery in some markets when compared with the prior year.

 

Overall, annual Group sales were £36.9m (2024: £29.2m) with sales increasing in all key areas. New product development is key to future business development; the development of our Chest and Respiratory Examination (CaRE) trainer continue to be well received by all markets, and the Arterial Puncture Wrist, launched during 2025, has performed very well.

 

The business also ended 2025 with a strong order book, and this bodes well for the start of 2026. The business has ceased its exclusivity arrangements for the distribution of Trucorp products, focusing on expanding own product development whilst still developing its position as a provider of choice.

 

With the global economy still being impacted by geo-political events, inflation was again running at slightly higher than expected levels for the year; however, the business has managed these increased costs. Equally, the business is also aware of the impact of higher inflation on all staff and continues to invest in both remuneration and welfare.

 

The business continues to evolve its currency hedging strategy to balance the impact of currency fluctuations on its profitability and valuation of foreign currency assets, although currencies used were less volatile during year. Productivity has improved with the continued investments manufacturing facilities, equipment and key processes, and will be further enhanced by the redeveloped buildings previously purchased.

 

The Business has also continued to invest in its IT infrastructure to support its future growth forecasts.

 

The Business has continued its people investment, expanded the team and skill base, and supporting its continued focus on future growth and market development. A continued focus for 2025 has been investment in New Product Development through the continued expansion of the R&D function.

 

The Company made £85k (2024: £141 k) in charitable donations in the year to local food banks and charities in recognition of the ongoing hardship of residents impacted by cost of living issues.

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

GROUP STRATEGIC REPORT (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

 

Principal risks and uncertainties

 

Sales

 

Sales generation is the key business risk and the business is exposed to downturns in healthcare expenditure in its key markets. Competition continues to grow with the increasing recognition of the benefits of simulation in healthcare and the sector’s growth.

 

Product quality

 

As a manufacturer, the quality of products delivered to customers is a key business risk; issues with product design or quality can erode customer confidence over time, and our Customer Services team are in contact across our customer base to identify these issues and ensure appropriate corrective action is taken.

 

People

 

Attracting and retaining talented personnel is key to future business development; the Business has continued to invest in staff across all areas of the Business, through remuneration, benefits and personal and professional development. Our Employee Forum continues to liaise with all staff to listen and respond with appropriate actions.

 

Safety

 

Employee safety is of paramount importance, for both physical and mental health; mental health concerns still prevail and there is a team of Mental Health First Aiders available for those who require this facility. Physical safety also continues to be a principal priority, with operations areas properly segregated and appropriate PPE being worn.

 

Financial key performance indicators

 

The Board and senior leadership team of Limbs & Things rely on the following KPIs:

-

Sales and gross margin at Group and Business Unit level;

-

EBIT margin at Group and Business Unit level;

-

Number of reportable accidents; and

-

Customer lead times.

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

GROUP STRATEGIC REPORT (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

 

The Business remains focused on developing and supplying high quality products which enhance clinical training for our customers worldwide. Sales of "own manufactured” product has increased slightly as a proportion of the Business to 82% of total sales (2024 : 81%), but still demonstrates a high level of acceptance for Limbs & Things’ branded products in the marketplace, plus the benefit of offering quality products from other providers. Investment in new products will continue to be a key strategy for the Group.

 

In the prior year, the Business recruited an Environmental, Social & Governance (ESG) Manager with the following remit:

 

•

develop and implement ESG policies that align with the company's values and mission.

 

 

•

engage with stakeholders, including shareholders, customers and employees on ESG matters; and

 

 

•

report on ESG performance and progress to senior management and the board of directors.

 

The year under review has been used for generating benchmarking data with which to demonstrate improved sustainability measures going forward. Additionally, we have also achieved bronze certification from EcoVadis, a global sustainability ratings platform, demonstrating that the Business is clearly on the correct trajectory in this respect.

 

There were no reportable accidents during 2025.

 

This report was approved by the board and signed on its behalf.

 

 

 

 

 

N Hull

Director

Date: 2nd June 2026

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

DIRECTORS’ REPORT

FOR THE YEAR ENDED 31 DECEMBER 2025

 

The directors present their report and the financial statements for the year ended 31 December 2025.

 

Directors’ responsibilities statement

 

The directors are responsible for preparing the Group Strategic Report, the Directors’ Report and the consolidated financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and the Group and of the profit or loss of the Group for that period.

 

In preparing these financial statements, the directors are required to:

•

select suitable accounting policies for the Group's financial statements and then apply them consistently;

•

make judgements and accounting estimates that are reasonable and prudent;

•

state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and

•

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Group will continue in business.

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company’s transactions and disclose with reasonable accuracy at any time the financial position of the Company and the Group and to enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Company and the Group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

 

The directors are responsible for the maintenance and integrity of the corporate and financial information included on the Group's website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements and other information included in Directors’ Reports may differ from legislation in other jurisdictions.

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

DIRECTORS’ REPORT (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

 

Results and dividends

 

The profit for the year, after taxation, amounted to £6,541,078 (2024 - £4,166,863).

 

Dividends of £945,000 were paid during the year (2024 - £1,181,100).

 

Directors

 

The directors who served during the year were:

C M Cooper

R Braso

A Allin

N Hull

T Cooper

M Jackson (resigned 13th October 2025)

 

Future developments

 

The directors aim to maintain the management policies which have resulted in the group’s growth in recent years. Two nearby properties were purchased during 2024, and these were redeveloped to allow for increased production capacity and opened in early 2026.

 

Financial instruments

 

The Group's financial instruments include various assets and liabilities such as trade receivables, trade payables and derivative financial instruments for foreign exchange arising directly from its operations, and cash.

 

Matters covered in the Group Strategic Report

 

Details of the Group’s principal activities are covered in the Strategic Report.

 

Disclosure of information to auditor

 

Each of the persons who are directors at the time when this Directors' Report is approved has confirmed that:

 

•

so far as the director is aware, there is no relevant audit information of which the Company and the Group's auditor is unaware, and

•

the director has taken all the steps that ought to have been taken as a director in order to be aware of any relevant audit information and to establish that the Company and the Group's auditor is aware of that information.

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

DIRECTORS’ REPORT (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

 

Economic impact of global events

 

UK businesses are currently facing many uncertainties such as the consequences of geopolitical events, rising levels of inflation globally, increased environmental issues and a greater threat from cybersecurity. These uncertainties have contributed to an environment where there exists a range of issues and risks, including inflation, rising interest rates, labour shortages, disrupted supply chains and new ways of working.

 

The Directors have carried out an assessment of the potential impact of these uncertainties on the business, including the impact of mitigation measures, and have concluded that these are non-adjusting events with the greatest impact on the business expected to be from the economic ripple effect on the global economy. The Directors have taken account of these potential impacts in their going concern assessment.

 

Limbs & Things Limited continues to work with its partners to minimise any impacts of these events and maximise the realisation of any opportunities they may provide to the business.

 

Auditor

 

The auditor, Forvis Mazars LLP, will be proposed for reappointment in accordance with section 485 of the Companies Act 2006.

 

This report was approved by the board and signed on its behalf.

 

 

 

 

 

 

 

N Hull

Director

Date: 2nd June 2026

INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

Opinion

 

We have audited the financial statements of Limbs and Things Limited (the ‘company’) and its subsidiaries (the ‘group’) for the year ended 31 December 2025 which comprise the Consolidated Statement of Comprehensive Income, the Consolidated and Company Balance Sheets, the Consolidated and Company Statement of Changes in Equity, the Consolidated Statement of Cash Flows and notes to the financial statements, including a summary of significant accounting policies.

 

The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (United Kingdom Generally Accepted Accounting Practice).

 

In our opinion the financial statements:

 

•

give a true and fair view of the state of the group’s and of the parent company’s affairs as at 31 December 2025 and of the group’s and the parent company’s profit for the year then ended;

 

 

•

have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

 

 

•

have been prepared in accordance with the requirements of the Companies Act 2006.

 

Basis for opinion

 

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the “Auditor’s responsibilities for the audit of the financial statements” section of our report. We are independent of the group and the parent company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

 

Conclusions relating to going concern

 

In auditing the financial statements, we have concluded that the director’s use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and the parent company’s ability to continue as a going concern fora period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report

INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

Other information

 

The other information comprises the information included in the Strategic and Directors' Report, other than the financial statements and our auditor’s report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

 

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

 

Opinions on other matters prescribed by the Companies Act 2006

 

In our opinion, based on the work undertaken in the course of the audit:

 

•

the information given in the Strategic Report and the Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

 

 

•

the Strategic Report and the Directors' Report have been prepared in accordance with applicable legal requirements.

 

Matters on which we are required to report by exception

 

In light of the knowledge and understanding of the group and the parent company and their environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors’ report.

 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

 

•

adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or

 

 

•

the financial statements are not in agreement with the accounting records and returns; or

 

 

•

certain disclosures of directors’ remuneration specified by law are not made; or

 

 

•

we have not received all the information and explanations we require for our audit.

INDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OF LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

Responsibilities of Directors

 

As explained more fully in the directors’ responsibilities statement set out on page 4, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

 

In preparing the financial statements, the directors are responsible for assessing the group’s and the parent company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or the parent company or to cease operations, or have no realistic alternative but to do so.

 

Auditor’s responsibilities for the audit of the financial statements

 

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of the financial statements.

 

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below.

 

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud.

 

Based on our understanding of the group and the parent company and its industry, we considered that non- compliance with the following laws and regulations might have a material effect on the financial statements: employment regulation and health and safety regulation, anti-bribery, corruption and fraud, money laundering.

 

To help us identify instances of non-compliance with these laws and regulations, and in identifying and assessing the risks of material misstatement in respect to non-compliance, our procedures included, but were not limited to:

 

•

Inquiring of management and, where appropriate, those charged with governance, as to whether the group and the parent company is in compliance with laws and regulations, and discussing their policies and procedures regarding compliance with laws and regulations;

 

 

•

Inspecting correspondence, if any, with relevant licensing or regulatory authorities;

 

 

•

Communicating identified laws and regulations to the engagement team and remaining alert to any indications of non-compliance throughout our audit; and

 

 

•

Considering the risk of acts by the group and the parent company which were contrary to applicable laws and regulations, including fraud.

INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

We also considered those laws and regulations that have a direct impact on the preparation of the financial statements, such as UK tax legislation, pensions legislation, and the Companies Act 2006.

 

In addition, we evaluated the directors’ and management’s incentives and opportunities for fraudulent manipulation of the financial statements, including the risk of override of controls, and determined that the principal risks were related to posting manual journal entries to manipulate financial performance, management bias through judgements and assumptions in significant accounting estimates, revenue recognition (which we pinpointed to the cut-off assertion), and significant one-off or unusual transactions.

 

Our audit procedures in relation to fraud included but were not limited to:

 

•

Making enquiries of the directors and management on whether they had knowledge of any actual, suspected or alleged fraud;

 

 

•

Gaining an understanding of the internal controls established to mitigate risks related to fraud;

 

 

•

Discussing amongst the engagement team the risks of fraud; and

 

 

•

Addressing the risks of fraud through management override of controls by performing journal entry testing.

 

There are inherent limitations in the audit procedures described above and the primary responsibility for the prevention and detection of irregularities including fraud rests with management. As with any audit, there remained a risk of non-detection of irregularities, as these may involve collusion, forgery, intentional omissions, misrepresentations or the override of internal controls.

 

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

 

Use of the audit report

 

This report is made solely to the company’s members as a body in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body for our audit work, for this report, or for the opinions we have formed.

 

 

 

 

Jonathan Marchant (Senior Statutory Auditor)

for and on behalf of Forvis Mazars LLP

Chartered Accountants and Statutory Auditor

8th Floor Assembly Building C

Cheese Lane

Bristol

BS2 0JJ

 

Date:

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

FOR THE YEAR ENDED 31 DECEMBER 2025

 

 

Note

2025

2024

 

 

£

£

 

 

 

 

Turnover

4

36,870,09429,171,196

Cost of sales

 

(18,939,115)

(15,420,926)

 

 

 

 

Gross profit

 

17,930,97913,750,270

 

 

 

 

Distribution costs

 

(2,010,431)

(1,761,094)

Administrative expenses

 

(7,533,645)

(6,995,996)

Other operating income

5

250,71719,614

 

 

 

 

Operating profit

6

8,637,6205,012,794

 

 

 

 

Interest receivable

10

312,024239,283

Fair value adjustment

 

10,901122,895

 

 

 

 

Profit before tax

 

8,960,5455,374,972

 

 

 

 

Tax on profit

11

(2,419,467)

(1,208,109)

 

 

 

 

Profit for the financial year

 

6,541,0784,166,863

 

 

 

 

Other comprehensive Income:

 

 

 

Items that will not be reclassified to profit or loss:

 

 

 

Currency translation differences

 

(152,824)

(20,053)

 

 

 

 

Total comprehensive income for the year

 

6,388,2544,146,810

 

 

 

 

Profit for the year attributable to:

 

 

 

Owners of the parent company

 

6,541,0784,166,863

 

 

 

 

 

 

6,541,0784,166,863

 

There were no recognised gains and losses for 2025 or 2024 other than those included in the consolidated statement of comprehensive income.

 

The notes on pages 21 to 42 form part of these financial statements.

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

CONSOLIDATED BALANCE SHEET

AS AT 31 DECEMBER 2025

 

 

 

 

2025

 

2024

 

Note

 

£

 

£

 

 

 

 

 

 

Fixed assets

 

 

 

 

 

Intangible assets

13

 

628,518

 

669,864

Tangible assets

14

 

6,750,975

 

5,347,035

 

 

 

 

 

 

 

 

 

7,379,493

 

6,016,899

 

 

 

 

 

 

Current assets

 

 

 

 

 

Stocks

16

3,539,894

 

4,152,799

 

Debtors: amounts falling due within one year

17

5,420,495

 

4,451,596

 

Current asset investments

18

6,021,073

 

6,020,537

 

Cash at bank and in hand

19

10,326,257

 

5,495,102

 

 

 

 

 

 

 

 

 

25,307,719

 

20,120,034

 

Creditors: amounts falling due within one year

20

(4,262,866)

 

(3,164,768)

 

 

 

 

 

 

 

Net current assets

 

 

21,044,853

 

16,955,266

 

 

 

 

 

 

Total assets less current liabilities

 

 

28,424,346

 

22,972,165

 

 

 

 

 

 

Provisions for liabilities

 

 

 

 

 

Deferred taxation

22

(916,375)

 

(907,448)

 

 

 

 

 

 

 

 

 

 

(916,375)

 

(907,448)

 

 

 

 

 

 

Net assets

 

 

27,507,971

 

22,064,717

 

 

 

 

 

 

Capital and reserves

 

 

 

 

 

Called up share capital

23

 

742

 

742

Share premium account

 

 

99,200

 

99,200

Capital redemption reserve

 

 

158

 

158

Other reserves

 

 

(5,265,658)

 

(5,265,658)

Profit and loss account

 

 

32,673,529

 

27,230,275

 

 

 

 

 

 

 

 

 

27,507,971

 

22,064,717

 

 

 

 

N Hull

Director

Date: 2nd June 2026

 

The notes on pages 21 to 42 form part of these financial statements.

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

COMPANY BALANCE SHEET

AS AT 31 DECEMBER 2025

 

 

 

 

2025

 

2024

 

Note

 

£

 

£

 

 

 

 

 

 

Fixed assets

 

 

 

 

 

Intangible assets

13

 

628,518

 

669,864

Tangible assets

14

 

6,719,259

 

5,263,452

Investments

15

 

623

 

74,019

 

 

 

 

 

 

 

 

 

7,348,400

 

6,007,335

Current assets

 

 

 

 

 

Stocks

16

2,382,838

 

2,969,101

 

Debtors: amounts falling due within one year

17

4,725,488

 

4,235,413

 

Current asset investments

18

6,021,073

 

6,020,537

 

Cash at bank and in hand

19

7,629,105

 

3,426,720

 

 

 

 

 

 

 

 

 

20,758,504

 

16,651,771

 

Creditors: amounts falling due within one year

20

(2,714,547)

 

(2,140,225)

 

 

 

 

 

 

 

Net current assets

 

 

18,043,957

 

14,511,546

 

 

 

 

 

 

Total assets less current liabilities

 

 

25,392,357

 

20,518,881

 

 

 

 

 

 

Provisions for liabilities

 

 

 

 

 

Deferred taxation

22

(574,564)

 

(554,317)

 

 

 

 

 

 

 

 

 

 

(574,564)

 

(554,317)

 

 

 

 

 

 

Net assets

 

 

24,817,793

 

19,964,564

 

 

 

 

 

 

Capital and reserves

 

 

 

 

 

Called up share capital

23

 

742

 

742

Share premium account

 

 

99,200

 

99,200

Capital redemption reserve

 

 

158

 

158

Other reserves

 

 

(5,265,658)

 

(5,265,658)

Profit and loss account

 

 

29,983,351

 

25,130,122

 

 

 

 

 

 

 

 

 

24,817,793

 

19,964,564

 

 

 

 

N Hull

Director

Date: 2nd June 2026

 

The notes on pages 21 to 42 form part of these financial statements.

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

FOR THE YEAR ENDED 31 DECEMBER 2025

 

 

Called up

share

capital

Share

premium

account

Capital

redemption

reserve

Investment

In own

shares

Profit and

loss

account

Total

equity

 

£

£

£

£

£

£

 

 

 

 

 

 

 

Al 1 January 2025

74299,200158

(5,265,658)

27,230,27522,064,717

 

 

 

 

 

 

 

Comprehensive income for the year

 

 

 

 

 

 

 

 

 

 

 

 

 

Profit for the year

-

-

-

-

6,541,0786,541,078

 

 

 

 

 

 

 

Currency translation differences

-

-

-

-

(152,824)

(152,824)

 

 

 

 

 

 

 

Other comprehensive income for the year

-

-

-

-

(152,824)

(152,824)

 

 

 

 

 

 

 

Total comprehensive Income for the year

-

-

-

-

6,388,2546,388,254

 

 

 

 

 

 

 

Contributions by and distributions to owners

 

 

 

 

 

 

 

 

 

 

 

 

 

Dividends: Equity capital

-

-

-

-

(945,000)

(945,000)

 

 

 

 

 

 

 

Total transactions with owners

-

-

-

-

(945,000)

(945,000)

 

 

 

 

 

 

 

At 31 December 2025

74299,200158

(5,265,658)

32,673,52927,507,971

 

The notes on pages 21 to 42 form part of these financial statements.

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

FOR THE YEAR ENDED 31 DECEMBER 2024

 

 

Called up share capital

Share premium account

Capital redemption reserve

Investment in own shares

Profit and loss account

Total equity

 

£

£

£

£

£

£

 

 

 

 

 

 

 

At 1 January 2024

74299,200158

(5,000,000)

24,264,56519,364,665

 

 

 

 

 

 

 

Comprehensive income for the year

 

 

 

 

 

 

 

 

 

 

 

 

 

Profit for the year

-

-

-

-

4,166,8634,166,863

 

 

 

 

 

 

 

Currency translation differences

-

-

-

-

(20,053)

(20,053)

 

 

 

 

 

 

 

Other comprehensive income for the year

-

-

-

-

(20,053)

(20,053)

 

 

 

 

 

 

 

Total comprehensive income lor the year

-

-

-

-

4,146,8104,146,810

 

 

 

 

 

 

 

Contributions by and distributions to owners

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of share options exercised in the year

-

-

-

(265,658)

 

(265,658)

 

 

 

 

 

 

 

Dividends: Equity capital

-

-

-

 

(1,181,100)

(1,181,100)

 

 

 

 

 

 

 

Total transactions with owners

-

-

-

(265,658)

(1,181,100)

(1,446,758)

 

 

 

 

 

 

 

At 31 December 2024

74299,200158

(5,265,658)

27,230,27522,064,717

 

The notes on pages 21 to 42 form part of these financial statements.

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

COMPANY STATEMENT OF CHANGES IN EQUITY

FOR THE YEAR ENDED 31 DECEMBER 2025

 

 

Called up Share capital

Share premium account

Capital redemption reserve

investment in own shares

Profit and loss account

Total equity

 

£

£

£

£

£

£

 

 

 

 

 

 

 

At 1 January 2025

74299,200158

(5,265,658)

25,130,12219,964,564

 

 

 

 

 

 

 

Comprehensive Income for the year

 

 

 

 

 

 

 

 

 

 

 

 

 

Profit for the year

-

-

-

-

5,798,2295,798,229

 

 

 

 

 

 

 

Total comprehensive income for the year

-

-

-

-

5,798,2295,798,229

 

 

 

 

 

 

 

Contributions by and distributions to owners

-

-

-

-

-

-

 

 

 

 

 

 

 

Dividends: Equity capital

-

-

-

-

(945,000)

(945,000)

 

 

 

 

 

 

 

Total transactions with owners

-

-

-

-

(945,000)

(945,000)

 

 

 

 

 

 

 

At 31 December 2025

74299,200158

(5,265,658)

29,983,35124,817,793

 

The notes on pages 21 to 42 form part of these financial statements.

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

COMPANY STATEMENT OF CHANGES IN EQUITY

FOR THE YEAR ENDED 31 DECEMBER 2024

 

 

Called up share capital

Share premium account

Capital redemption reserve

Investment

In own

shares

Profit and loss account

Total Equity

 

£

£

£

£

£

£

 

 

 

 

 

 

 

At 1 January 2024

74299,200158

(5,000,000)

23,209,33718,309,437

 

 

 

 

 

 

 

Comprehensive income for the year

 

 

 

 

 

 

 

 

 

 

 

 

 

Profit for the year

-

-

-

-

3,101,8853,101,885

 

 

 

 

 

 

 

Total comprehensive income for the year

-

-

-

 

3,101,8853,101,885

 

 

 

 

 

 

 

Contributions by and distributions to owners

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of share options exercised in the year

-

-

-

(265,658)

-

(265,658)

Dividends: Equity capital

-

-

-

-

(1,181,100)

(1,181,100)

 

 

 

 

 

 

 

Total transactions with owners

-

-

-

(265,658)

(1,181,100)

(1,446,758)

 

 

 

 

 

 

 

At 31 December 2024

74299,200158

(5,265,658)

25,130,12219,964,564

 

The notes on pages 21 to 42 form part of these financial statements.

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

CONSOLIDATED STATEMENT OF CASH FLOWS

FOR THE YEAR ENDED 31 DECEMBER 2025

 

 

Note

2025

2024

 

 

£

£

 

 

 

 

Cash flows from operating activities

 

 

 

 

 

 

 

Profit for the financial year

 

6,541,0784,166,863

 

 

 

 

Adjustments for:

 

 

 

 

 

 

 

Amortisation of intangible assets

 

130,162107,050

Depreciation of tangible assets

 

987,532850,104

Currency translation services

 

(152,824)

(20,053)

Interest received

 

(312,024)

(239,283)

Taxation charge

 

2,419,4671,208,109

Decrease/(lncrease) in stocks

 

612,903

(600,462)

(Increase) in debtors

 

(1,056,158)

(163,755)

lncrease/(decrease) in creditors

 

145,260

(119,961)

Corporation tax (paid)

 

(1,370,441)

(1,335,031)

 

 

 

 

Net cash generated from operating activities

 

7,944,9553,853,581

 

 

 

 

Cash flows from investing activities

 

 

 

Purchase of intangible fixed assets

13

(88,816)

(129,795)

Purchase of tangible fixed assets

14

(2,391,472)

(2,339,100)

Sale of tangible fixed assets

14

-

6,303

Placement of term deposits

 

(536)

(3,015,487)

Interest received

 

312,024239,283

 

 

 

 

Net cash (used in) / from investing activities

 

(2,168,800)

(5,238,796)

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

CONSOLIDATED STATEMENT OF CASH FLOWS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

 

 

2025

2024

 

£

£

 

 

 

Cash flows from financing activities

 

 

 

 

 

Dividends paid

(945,000)

(1,181,100)

Share options exercised

-

(265,658)

 

 

 

Net cash used in financing activities

(945,000)

(1,446,758)

 

 

 

Net increase in cash and cash equivalents

4,831,155

(2,831,973)

 

 

 

Cash and cash equivalents at beginning of year

5,495,1028,327,075

 

 

 

Cash and cash equivalents at the end of year

10,326,2575,495,102

 

 

 

Cash and cash equivalents at the end of year comprise:

 

 

 

 

 

Cash at bank and in hand

10,326,2575,495,102

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

CONSOLIDATED ANALYSIS OF NET DEBT

FOR THE YEAR ENDED 31 DECEMBER 2025

 

 

At 1

January

 

At 31 December

 

2025

Cash flows

2025

 

£

£

£

 

 

 

 

Cash at bank and in hand

5,495,1024,831,15510,326,257

 

 

 

 

 

5,495,1024,831,15510,326,257

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

 

1.     General information

 

Limbs & Things Limited is a private company limited by shares and incorporated in England, registered number 02532281. The Registered Office is Sussex Street, St Philips, Bristol, BS2 ORA.

 

The Group’s principal activities during the year continued to be the manufacture and distribution of medical training products.

 

2.     Accounting policies

 

2.1     Basis of preparation of financial statements

 

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

 

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires Group management to exercise judgement in applying the Group's accounting policies (see note 3).

 

The Company has taken advantage of the exemption allowed under section 408 of the Companies Act 2006 and has not presented its own Statement of Comprehensive income in these financial statements.

 

The Company’s profit for the year was £5,798,229 (2024: £3,101,885).

 

The following principal accounting policies have been applied:

 

2.2     Basis of consolidation

 

The consolidated financial statements present the results of the Company and its own subsidiaries (the Group”) as if they form a single entity. Intercompany transactions and balances between group companies are therefore eliminated in full.

 

The consolidated financial statements incorporate the results of business combinations using the purchase method. In the Balance Sheet, the acquiree's identifiable assets, liabilities and contingent liabilities are initially recognised at their fair values at the acquisition date. The results of acquired operations are included in the Consolidated Statement of Comprehensive Income from the date on which control is obtained. They are deconsolidated from the date control ceases.

 

In accordance with the transitional exemption available in FRS 102, the group has chosen not to retrospectively apply the standard to business combinations that occurred before the date of transition to FRS 102, being 01 January 2014.

 

2.3     Going concern

 

Following a review of the Groups future forecasts and projections the Directors are confident that the Group has sufficient resources to continue its operational existence for the foreseeable future. The Group therefore continues to adopt the “going concern” basis in preparing its consolidated financial statements.

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

 

2.      Accounting policies (continued)

 

2.4      Foreign currency translation

 

Functional and presentation currency

 

The Company’s functional and presentational currency is GBP and the financial statements are rounded to the nearest £.

 

Transactions and balances

 

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

 

At each period end foreign currency monetary items are translated using the closing rate. Nonmonetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non monetary items measured at fair value are measured using the exchange rate when fair value was determined.

 

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

 

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Consolidated Statement of Comprehensive Income within 'finance income or costs". All other foreign exchange gains and losses are presented in profit or loss within ‘administrative expenses’.

 

On consolidation, the results of overseas operations are translated into Sterling at rates approximating to those ruling when the transactions took place. All assets and liabilities of overseas operations are translated at the rate ruling at the reporting date. Exchange differences arising on translating the opening net assets at opening rate and the results of overseas operations at actual rate are recognised in other comprehensive income.

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

 

2.      Accounting policies (continued)

 

2.5     Revenue

 

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Group and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

 

Sale of goods

 

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:

 

•

the Group has transferred the significant risks and rewards of ownership to the buyer;

 

 

•

the Group retains neither continuing managerial involvement to the degree usually associated;

 

 

•

with ownership nor effective control over the goods sold;

 

 

•

the amount of revenue can be measured reliably,

 

 

•

it is probable that the Group will receive the consideration due under the transaction; and

 

 

•

the costs incurred or to be incurred in respect of the transaction can be measured reliably.

 

Rendering of services

 

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:

 

•

the amount of revenue can be measured reliably,

 

 

•

it is probable that the Group will receive the consideration due under the contract;

 

 

•

The stage of completion of the contract at the end of the reporting period can be measured reliably; and

 

 

•

the costs incurred and the costs to complete the contract can be measured reliably.

 

2.6     Operating leases: the Group as lessee

 

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

 

2.     Accounting policies (continued)

 

2.7     Research and development

 

In the research phase of an internal project it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research shall be recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific criteria are met in order to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured. The capitalised development costs are subsequently amortised on a straight line basis over their useful economic lives, which range from 3 to 6 years.

 

If it is not possible to distinguish between the research phase and the development phase of an internal project, the expenditure is treated as if it were all incurred in the research phase only.

 

Where feasible, the Company will claim tax relief for specific research and development work. In previous years, this was a credit to the taxation charge for the year as determined by the SME scheme. For the year under review, the SME scheme has been replaced by the merged Research and Development Expenditure (RDEC) scheme, where the gross tax credit is reported as Other Operating Income.

 

2.8     Interest income

 

Interest income is recognised in profit or loss using the cash received during the period.

 

2.9     Finance costs

 

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 

2.10     Pensions

 

Defined contribution pension plan

 

The Group operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Group pays fixed contributions into a separate entity. Once the contributions have been paid the Group has no further payment obligations.

 

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Group in independently administered funds.

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

 

2.     Accounting policies (continued)

 

2.11     Current and deferred taxation

 

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

 

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company and the Group operate and generate income.

 

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:

 

•

The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits;

 

 

•

Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met; and

 

 

•

Where they relate to timing differences in respect of interests in subsidiaries, associates, branches and joint ventures and the Group can control the reversal of the timing differences and such reversal is not considered probable in the foreseeable future.

 

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

 

2.12     Intangible assets

 

Goodwill represents the difference between the cost of a business combination and the Group’s interest in the fair value of the identifiable assets and liabilities of the acquiree at the acquisition date. Subsequent to initial recognition, goodwill is measured at cost less accumulated amortisation and accumulated impairment losses (which are not reversed).

 

Goodwill can be subsequently adjusted for changes to estimates of contingent considerations given in a business combination.

 

Goodwill is amortised on a straight-line basis over its useful economic life. This is assessed individually for each acquisition taking into account the period over which the Group expects to realise the synergies from the combination. In the rare situation that a reliable estimate cannot be made the useful life would be set to ten years, but this does not apply at present.

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

 

2.     Accounting policies (continued)

 

2.12     Intangible assets (continued)

 

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

 

At each reporting date the company assesses whether there is any indication of impairment. If such indication exists, the recoverable amount of the asset is determined which is the higher of its fair value less costs to sell and its value in use. An impairment loss is recognised where the carrying amount exceeds the recoverable amount.

 

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 

Intangible assets are amortised over their useful economic lives using a straight-line method as follows:

 

Goodwill

-

20%

 

 

 

Patents

-

25%

 

 

 

Software assets

-

25%

 

2.13     Development costs

 

Research and development expenditure is written off in the year in which it is incurred.

 

2.14     Tangible fixed assets

 

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

 

At each reporting date the company assesses whether there is any indication of impairment, if such indication exists, the recoverable amount of the asset is determined which is the higher of its fair value less costs to sell and its value in use. An impairment loss is recognised where the carrying amount exceeds the recoverable amount.

 

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

 

Depreciation is provided on the following basis:

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

 

2.     Accounting policies (continued)

 

2.14     Tangible fixed assets (continued)

 

Plants machinery

-

25%

 

 

 

Motor vehicles

-

25%

 

 

 

Furniture & fixtures

-

25%

 

 

 

Leasehold improvements

-

25%

 

 

 

Computer equipment

-

25%

 

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

 

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 

2.15     Stocks

 

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods do not include labour and attributable overheads.

 

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 

2.16     Debtors

 

Short-term debtors are measured at transaction price, less any impairment Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 

2.17     Current asset investments

 

Current asset investments are represented by deposits with financial institutions that mature more than 3 months from the date of acquisition, but have insignificant risk of change in value, and are measured subsequently at amortised cost using the effective interest method.

 

2.18     Cash and cash equivalents

 

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than 3 months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 

In the Consolidated Statement of Cash Flows, cash and cash equivalents are shown net of bank overdrafts that are repayable on demand.

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

 

2.     Accounting policies (continued)

 

2.19     Creditors

 

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 

2.20     Holiday pay accrual

 

In territories where there is a statutory requirement to accrue holiday pay, a liability is recognised to the extent of any unused holiday pay entitlement which is accrued at the Balance Sheet date and carried forward to future periods. This is measured at the undiscounted salary cost of the future holiday entitlement so accrued at the Balance Sheet date.

 

2.21     Provisions for liabilities

 

Provisions are made where an event has taken place that gives the Group a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation.

 

Provisions are charged as an expense to profit or loss in the year that the Group becomes aware of the obligation, and are measured at the best estimate at the balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties.

 

When payments are eventually made, they are charged to the provision carried in the Balance Sheet.

 

2.22     Financial instruments

 

The group recognises basis financial instruments and derivative financial instruments at fair value using a valuation technique with any gains and losses being reported in profit or loss. Outstanding derivatives at reporting date are included under the appropriate format heading depending on the nature of the derivative.

 

2.23     Dividends

 

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders.

 

Dividends on shares recognised as liabilities are recognised as expenses and classified within interest payable.

 

3.     Judgements in applying accounting policies and key sources of estimation uncertainty

 

There are no accounting estimates or judgements in applying accounting policies that, if incorrect, would lead to a material misstatement.

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

 

4.     Turnover

 

Analysis of turnover by country of destination:

 

 

2025

2024

 

£

£

 

 

 

United Kingdom

5,045,1575,099,587

Rest of World

13,017,34311,168,932

North America

18,807,59412,902,677

 

 

 

 

36,870,09429,171,196

 

5.     Other operating income

 

 

2025

2024

 

£

£

 

 

 

Other operating income

3,17717,167

Profit on disposal of tangible assets

1,6552,447

 

 

 

 

4,832

19,614

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

 

6.     Operating profit

 

The operating profit is stated after charging:

 

 

2025

2024

 

£

£

 

 

 

Research & development charged as an expense

 

-

Depreciation of tangible fixed assets

987,532850,104

Amortisation of intangible assets, including goodwill

130,162107,050

Exchange differences

(57,302)

13,561

Defined contribution pension cost

485,921475,048

 

7.     Auditor's remuneration

 

 

2025

2024

 

£

£

 

 

 

Fees payable to the Group's auditor and its associates for the audit of the

 

 

Group's annual accounts

21,94021,275

 

 

 

 

 

 

The auditing of accounts of associates of the Group pursuant to legislation

21,94021,275

Other services relating to taxation

7,7906,790

 

 

 

 

29,73028,065

 

8.     Employees

 

Staff costs, including directors’ remuneration, were as follows:

 

 

Group

Group

Company

Company

 

2025

2024

2025

2024

 

£

£

£

£

 

 

 

 

 

Wages and salaries

10,098,8159,866,4567,331,6577,113,616

Social security costs

918,067742,437879,105693,899

Cost of defined contribution scheme

485,921475,048376,978355,199

 

 

 

 

 

 

11,502,80311,083,9418,587,7408,162,714

 

The average monthly number of employees, including the directors, during the year was as follows:

 

 

2025

2024

 

 

 

 

219223

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

 

9.     Directors’ remuneration

 

 

2025

2024

 

£

£

 

 

 

Directors’ emoluments

906,983855,009

Group contributions to defined contribution pension schemes

46,64939,736

 

 

 

 

953,632894,745

 

During the year retirement benefits were accruing to 4 directors (2024 - 4) in respect of defined contribution pension schemes.

 

The highest paid director received remuneration of £260,606 (2024 - £196,199).

 

The value of the Group's contributions paid to a defined contribution pension scheme in respect of the highest paid director amounted to £15,970 (2024 - £15,474).

 

10.     Interest receivable

 

 

2025

2024

 

£

£

 

 

 

Other interest receivable

312,024239,283

 

 

 

 

312,024239,283

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

 

11.     Taxation

 

 

2025

2024

 

£

£

 

 

 

Corporation tax

 

 

Current tax on profits for the year

2,055,552704,782

Adjustments in respect of previous periods

(86,601)

(144,984)

 

 

 

Foreign tax

 

 

Foreign tax on income for the year

430,269415,135

 

 

 

 

430,269415,135

 

 

 

Total current tax

2,399,220974,933

 

 

 

Deferred tax

 

 

 

 

 

Origination and reversal of timing differences

(22,385)

38,661

Adjustments in respect of prior periods

42,632194,515

Effect of tax rate change on opening balance

-

-

 

 

 

Total deferred tax

20,247233,176

 

 

 

 

 

 

Taxation on profit on ordinary activities

2,419,4671,208,109

 

The tax assessed for the year is higher than (2024 - lower than) the standard rate of corporation tax in the UK of 25% (2024 - 25%). The differences are explained below:

 

 

2025

2024

 

£

£

 

 

 

Profit on ordinary activities before tax

8,960,545

5,374,448

Profit on ordinary activities multiplied by standard rate of corporation tax in the UK of 25% (2024-25%)

2,240,1361,343,612

Effects of:

 

 

Expenses not deductible for tax purposes

2,285939

Fixed asset differences

79,48470,336

Additional deduction for R&D expenditure

-

(305,838)

Adjustments to tax charge in respect of previous periods

(86,601)

(144,984)

Adjustments to tax charge in respect of previous periods - deferred tax

42,632194,515

Effects of overseas tax rates

(54,586)

(31,223)

Other differences leading to an increase in the tax charge

196,11780,752

 

 

 

Total tax charge for the year

2,419,4671,208,109

 

Factors that may affect future tax charges

 

There were no factors that may affect future tax charges.

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

 

12.     Dividends

 

 

2025

2024

 

£

£

 

 

 

Dividends

945,0001,181,100

 

 

 

 

945,0001,181,100

 

13.     Intangible assets

 

Group and Company

 

 

 

Software

 

 

 

Patent costs

costs

Goodwill

Total

 

£

£

£

£

 

 

 

 

 

Cost

 

 

 

 

At 1 January 2025

80,184477,527530,2841,087,995

Additions

20,29568,521

-

88,816

 

 

 

 

 

At 31 December 2025

100,479546,048530,2841,176,811

 

 

 

 

 

Amortisation

 

 

 

 

At 1 January 2025

4,027255,019159,085418,131

Charge for the year on owned assets

99323,112106,057130,162

 

 

 

 

 

At 31 December 2025

5,020278,131265,142548,293

 

 

 

 

 

Net book value

 

 

 

 

 

 

 

 

 

At 31 December 2025

95,459267,917265,142628,518

 

 

 

 

 

At 31 December 2024

76,157222,508371,199669,864

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

 

14.     Tangible fixed assets

 

Group

Long Term

Leasehold

property

improvements

Plants

machinery

Motor

vehicles

Fixtures &

fittings

Computer

equipment

Total

 

£

£

£

£

£

£

 

 

 

 

 

 

 

Cost or valuation

 

 

 

 

 

 

 

 

 

 

 

 

 

At 1 January 2025

4,541,0523,855,51970,367761,652856,52510,085,115

Additions

1,823,061215,71885,233139,804127,6562,391,472

 

 

 

 

 

 

 

At 31 December 2025

6,364,1134,071,237155,600901,456984,18112,476,587

 

 

 

 

 

 

 

Depreciation

 

 

 

 

 

 

 

 

 

 

 

 

 

At January 2025

879,7922,740,74120,795406,254690,4984,738,080

Charge for the year on owned assets

296,256453,30827,920124,63385,415987,532

 

 

 

 

 

 

 

At 31 December 2025

1,176,0483,194,04948,715530,887775,9135,725,612

 

 

 

 

 

 

 

Net book value

 

 

 

 

 

 

 

 

 

 

 

 

 

At 31 December 2025

5,188,065877,188106,885370,569208,2686,750,975

 

 

 

 

 

 

 

At 31 December 2024

3,661,2601,114,77849,572355,398166,0275,347,035

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

 

14.     Tangible fixed assets (continued)

 

Company

Long Term

Leasehold

property

improvements

Plant &

machinery

Motor

vehicles

Fixtures &

fittings

Computer

equipment

Total

 

£

£

£

£

£

£

 

 

 

 

 

 

 

Cost or valuation

 

 

 

 

 

 

 

 

 

 

 

 

 

At 1 January 2025

4,397,1493,855,51970,367408,179562,4439,293,657

Additions

1,823,061215,71885,233101,53859,1872,284,737

Disposals

 

 

 

 

 

 

 

 

 

 

 

 

 

At 31 December 2025

6,220,2104,071,237155,600509,717621,63011,578,394

 

 

 

 

 

 

 

Depreciation

 

 

 

 

 

 

 

 

 

 

 

 

 

At January 2025

691,3642,740,74220,795211,571365,7334,030,205

Charge for the year on owned assets

211,878453,30827,92063,82671,998828,930

Disposals

-

-

-

-

-

-

 

 

 

 

 

 

 

At 31 December 2025

903,2423,194,05048,715275,397437,7314,859,135

 

 

 

 

 

 

 

Net book value

 

 

 

 

 

 

 

 

 

 

 

 

 

At 31 December 2025

5,316,968877,187106,885234,320183,8996,719,259

 

 

 

 

 

 

 

At 31 December 2024

3,705,7851,114,77749,572196,608196,7105,263,452

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

 

15.     Fixed asset investments

 

 

Company

 

 

Investments

 

in

 

subsidiary

 

companies

 

£

 

 

Cost or valuation

 

At 1 January 2025

74,019

Dissolution of eoSurgical Ltd

(73,396)

 

 

At 31 December 2025

623

 

Subsidiary undertakings

 

The following were subsidiary undertakings of the Company:

 

Name

Registered office

Principal activity

Class of

Holding

 

 

 

 

 

 

 

 

shares

 

Limbs & Things Inc

USA

The distribution of anatomical devices

Ordinary

100

%

Limbs & Things Australia

Australia

The distribution of anatomical devices

Ordinary

100

%

K.Waldemar Larsson AB

Sweden

The sale of medical equipment and materials

Ordinary

100

%

eoSurgical Limited*

UK

The sale of medical equipment and materials

Ordinary

100

%

Limbs & Things Employee Trustee Limited

UK

Trustee of Limbs & Things Employee Benefit Trust

Ordinary

100

%

 

 

*this subsidiary was dissolved on 15th April 2025

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

 

16.     Stocks

 

 

Group

Group

Company

Company

 

2025

2024

2025

2024

 

£

£

£

£

 

 

 

 

 

Raw materials and consumables

2,184,6102,350,3062,184,6102,350,306

 

 

 

 

 

Finished goods and goods for resale

1,355,2861,802,493198,228618,795

 

 

 

 

 

 

3,539,896

4,152,7992,382,8382,969,101

 

The difference between purchase price or production cost of stocks and their replacement cost is not material.

 

Stock recognised during the year as an expense was £9,363,187 (2024: £7,007,305).

 

17.     Debtors

 

 

Group

Group

Company

Company

 

2025

2024

2025

2024

 

£

£

£

£

 

 

 

 

 

Trade debtors

4,423,3873,535,0982,439,9211,667,687

Amounts owed by group undertakings

-

-

1,507,2891,900,397

Other debtors

152,73386,497139,934101,902

Prepayments and accrued income

844,375742,744638,344565,428

Tax recoverable

-

87,257

-

-

 

 

 

 

 

 

5,420,4954,451,5964,725,4884,235,414

 

18.     Current asset investments

 

 

Group

Group

Company

Company

 

2025

2024

2025

2024

 

£

£

£

£

 

 

 

 

 

Term deposits

6,021,0736,020,5376,021,0736,020,537

 

 

 

 

 

 

6,021,0736,020,5376,021,0736,020,537

 

Term deposits represent cash placed on term deposits, the initial term being less than 12 months. The interest rate on these deposits fall in the range 3.90% to 4.19% (2024:4.70% to 5.31%).

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

 

19.     Cash and cash equivalents

 

 

Group

Group

Company

Company

 

2025

2024

2025

2024

 

£

£

£

£

 

 

 

 

 

Cash at bank and in hand

10,326,2575,495,102

7,663,497

3,426,720

 

 

 

 

 

 

10,326,2575,495,1027,663,4973,426,720

 

20.     Creditors: Amounts falling due within one year

 

 

Group

Group

Company

Company

 

2025

2024

2025

2024

 

£

£

£

£

 

 

 

 

 

Trade creditors

810,217693,989251,875181,839

Amounts owed to group undertakings

-

-

13,50186,872

Corporation tax

1,363,817410,9791,064,864251,838

Other taxation and social security

174,743179,731175,088179,731

Other creditors

222,683349,37768,926247,017

Accruals and deferred income

1,691,4061,530,6921,140,2931,192,928

 

 

 

 

 

 

4,262,8663,164,7682,714,5472,140,225

 

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

 

21.     Financial instruments

 

 

Group

Group

Company

Company

 

2025

2024

2025

2024

 

£

£

£

£

Financial assets

 

 

 

 

 

 

 

 

 

Financial assets measured at fair value through profit or loss

10,326,2575,495,1027,663,4973,426,720

 

 

 

 

 

Financial assets that are debt instruments measured at amortised cost

10,597,1939,642,13110,021,3209,603,650

 

 

 

 

 

 

20,923,45015,137,23317,684,81713,030,370

 

 

 

 

 

Financial liabilities

 

 

 

 

 

 

 

 

 

Financial liabilities measured at amortised cost

(2,724,306)

(2,574,057)

(1,626,606)

(1,621,784)

 

Financial assets measured at fair value through profit or loss comprise cash at bank and in hand.

 

Financial assets measured at amortised cost comprise current asset investments, trade debtors, other debtors and monies due from group undertakings.

 

Financial liabilities measured at amortised cost comprise trade creditors, accruals and deferred income and other creditors.

 

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

 

22.     Deferred taxation

 

Group

 

 

 

2025

2024

 

£

£

 

 

 

At beginning of year

907,448479,876

Charged to profit or loss

8,927427,572

 

 

 

At end of year

916,375907,448

 

 

 

 

 

 

Company

 

 

 

2025

2024

 

£

£

 

 

 

At beginning of year

554,317321,141

Charged to profit or loss

20,247233,176

 

 

 

At end of year

574,564554,317

 

The provision for deferred taxation is made up as follows:

 

 

Group

Group

Company

Company

 

2025

2024

2025

2024

 

£

£

£

£

 

 

 

 

 

Accelerated capital allowances

636,031597,604592,588578,762

Short term timing differences

280,344309,844

(18,024)

(24,445)

Losses and other deductions

-

-

-

-

 

 

 

 

 

 

916,375907,448574,564554,317

 

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

 

23.     Share capital

 

 

2025

2024

 

£

£

 

 

 

Allotted, called up and fully paid

 

 

742 (2024 - 742) ordinary shares of £1.00 each

742742

 

24.     Employee Benefit Trust (EBT) and share based payments

 

The Company established the Employee Benefit Trust (EBT) in 2018 as a vehicle to hold shares in the Company for the benefit of key Group employees. The Company has an equity settled share option scheme in place as an incentive plan for senior management. Each option vests one year after issue and can be exercised on one day each year. The number and weighted average exercise price of the shares are disclosed in a table below. The directors have considered the fair value of the services received in exchange for these options over their life using a Black-Scholes model and concluded that the value is insignificant. As a result, they have not accounted for a share based payment charge in these financial statements. There were no changes to the terms of the plan during the year.

 

 

 

Weighted

 

Number

average

 

 

exercise

 

 

price

 

 

£

 

 

 

At 1 January 2025

6624,251

Issued during the year

6

 

Exercised during the year

-

 

 

 

 

At 31 December 2025

7225,558

 

 

 

Exercisable at 31 December 2025

6423,799

 

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

 

25.     Capital commitments

 

At 31 December 2025 the Group and Company had capital commitments as follows:

 

 

Group

Group

Company

Company

 

2025

2024

2025

2024

 

£

£

£

£

 

 

 

 

 

Commitments contracted for at 31 December

774,51567,059774,51567,059

 

 

 

 

 

 

774,51567,059774,51567,059

 

26.     Pension commitments

 

The UK Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the group in an independently administered fund. The pension cost charge represents contributions payable by the group to the fund and amounted to £471,061 (2024: £475,048).

 

27.     Commitments under operating leases

 

At 31 December 2025 the Group and the Company had future minimum lease payments due under non-cancellable operating leases for each of the following periods:

 

 

Group

Group

Company

Company

 

2025

2024

2025

2024

 

£

£

£

£

 

 

 

 

 

Not later than 1 year

142,751164,057142,751164,057

Later than 1 year and not later than 5 years

228,495360,778228,495360,778

Later than 5 years

1,729,1241,777,2111,729,1241,777,211

 

 

 

 

 

 

2,100,3702,302,0462,100,3702,302,046

 

LIMBS & THINGS LIMITED AND SUBSIDIARY UNDERTAKINGS

 

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

 

29.     Related party transactions

 

Key management personnel

 

All directors and certain senior employees who have authority and responsibility for planning, directing and controlling the activities of the Group are considered to be key management personnel. Total remuneration is respect of these individuals is £1,090,517 (2024 - £854,763). There are 7 people deemed to be key management personnel, including directors (2024 - 7).

 

The Group has taken advantage of the exemption available under Section 33 of FRS 102 to disclose transactions between Group Companies.

 

30.     Post balance sheet events

 

There are no significant events affecting the Group or Company following the year end.

 

31.     Controlling party

 

The directors do not consider there to be an ultimate controlling party.